T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Humana
HUM
|
+$2.57B |
| 2 |
GE Aerospace
GE
|
+$1.8B |
| 3 |
UnitedHealth
UNH
|
+$1.63B |
| 4 |
Marriott International
MAR
|
+$1.62B |
| 5 |
Apple
AAPL
|
+$1.3B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Boeing
BA
|
+$2.87B |
| 2 |
JPMorgan Chase
JPM
|
+$1.64B |
| 3 |
Nike
NKE
|
+$1.59B |
| 4 |
Becton Dickinson
BDX
|
+$1.46B |
| 5 |
Alibaba
BABA
|
+$1.32B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.97% |
| 2 | Healthcare | 18.52% |
| 3 | Consumer Discretionary | 13.26% |
| 4 | Financials | 12.08% |
| 5 | Communication Services | 10.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
426
Vodafone
VOD
$37.3B
| $189M | 0.03% |
13,761,281
-623,569
| -4% | -$11.1M |
|
427
Regency Centers
REG
$14B
| $189M | 0.03% |
4,922,149
-253,545
| -5% | -$14.6M |
|
428
RBC Bearings
RBC
$17.5B
| $188M | 0.03% |
1,666,579
+248,553
| +18% | +$38.5M |
|
429
Tapestry
TPR
$26.5B
| $187M | 0.03% |
14,434,001
+78,033
| +0.5% | +$1.83M |
|
430
Vulcan Materials
VMC
$36.2B
| $187M | 0.03% |
1,727,960
-120,005
| -6% | -$15.3M |
|
431
Kemper
KMPR
$1.56B
| $185M | 0.03% |
2,483,754
+238,107
| +11% | +$17.8M |
|
432
VeriSign
VRSN
$25.5B
| $184M | 0.03% |
1,018,976
+14,133
| +1% | +$2.78M |
|
433
Westamerica Bancorp
WABC
$1.38B
| $183M | 0.03% |
3,120,078
+61,705
| +2% | +$3.84M |
|
434
Suncor Energy
SU
$75.9B
| $183M | 0.03% |
11,601,050
+10,392,148
| +860% | +$272M |
|
|
HR
435
DELISTED
Healthcare Realty Trust Incorporated
HR
| $182M | 0.03% |
6,521,439
-1,465,344
| -18% | -$49.7M |
|
436
Pinnacle Financial Partners Inc
PNFP
$16.2B
| $181M | 0.03% |
4,816,034
+262,421
| +6% | +$14.2M |
|
437
Tenaris
TS
$26.7B
| $179M | 0.03% |
14,863,019
+5,331,178
| +56% | +$98M |
|
438
Douglas Emmett
DEI
$1.99B
| $178M | 0.03% |
5,850,300
+202,551
| +4% | +$7.89M |
|
439
Ionis Pharmaceuticals
IONS
$9.3B
| $178M | 0.03% |
3,762,445
+1,898,009
| +102% | +$106M |
|
440
BP
BP
$110B
| $177M | 0.03% |
7,242,742
-4,561,066
| -39% | -$147M |
|
441
Martin Marietta Materials
MLM
$32.8B
| $175M | 0.03% |
922,191
+6,413
| +0.7% | +$1.53M |
|
442
PG&E
PCG
$39.1B
| $173M | 0.03% |
19,288,723
+9,127,933
| +90% | +$121M |
|
443
Landstar System
LSTR
$6.39B
| $173M | 0.03% |
1,802,016
-170,107
| -9% | -$18.1M |
|
444
Teladoc Health
TDOC
$1.26B
| $173M | 0.03% |
1,113,395
+535,358
| +93% | +$62.3M |
|
445
CNA Financial
CNA
$13.7B
| $172M | 0.03% |
5,539,815
+383,549
| +7% | +$16.2M |
|
446
American Express
AXP
$230B
| $172M | 0.03% |
2,006,371
-2,372,349
| -54% | -$276M |
|
|
FLIR
447
DELISTED
FLIR Systems, Inc. (DE) Common Stock
FLIR
| $172M | 0.03% |
5,383,446
-1,586,587
| -23% | -$74.6M |
|
448
Alexandria Real Estate Equities
ARE
$8.32B
| $171M | 0.03% |
1,249,907
-172,329
| -12% | -$27M |
|
449
Penumbra
PEN
$12.9B
| $171M | 0.03% |
1,060,680
+136,795
| +15% | +$23M |
|
450
Lockheed Martin
LMT
$138B
| $171M | 0.03% |
504,034
+41,507
| +9% | +$16.3M |
|
Similar funds
T. Rowe Price Associates's Q1 2020 Portfolio in Review
As of Q1 2020, T. Rowe Price Associates held 2,612 positions worth $632B, down 18% from $771B the previous quarter. Its ten largest holdings account for 24% of the portfolio.
T. Rowe Price Associates's Q1 2020 filing shows 87 new, 1,525 increased, 823 reduced and 103 closed positions. Its largest new stake was Philips: 33,363,001 shares worth $1.07B. The largest sale was Boeing, an estimated $2.87B.
By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 21% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q1 2020 buy was Philips: 33,363,001 shares worth $1.07B.
- T. Rowe Price Associates added most to Humana in Q1 2020, an estimated $2.57B increase.
- T. Rowe Price Associates's biggest Q1 2020 reduction was Boeing, cutting an estimated $2.87B.
- T. Rowe Price Associates fully exited Wellcare Health Plans, Inc. in Q1 2020, selling an estimated $846M.
- T. Rowe Price Associates's ten largest holdings make up 24% of its $632B portfolio in Q1 2020.
- T. Rowe Price Associates opened 87 new positions and closed 103 in Q1 2020.
- T. Rowe Price Associates's portfolio value fell 18% quarter-over-quarter to $632B.
Based on T. Rowe Price Associates's 13F filing for Q1 2020, filed 15 May 2020.